Related Experiment Videos
Alternatives to unmodified human islets for transplantation
Alberto Hayek1, Gillian M Beattie
1Whittier Institute, UCSD Department of Pediatrics, 0831, 9500 Gilman Drive, La Jolla, CA 92093-0831, USA. ahayek@ucsd.edu
Current Diabetes Reports
|March 20, 2003
Summary
Islet transplantation shows promise for type 1 diabetes, but organ scarcity is a major hurdle. Researchers are exploring alternative human and nonhuman cell sources to increase tissue availability for patients.
Area of Science:
- Endocrinology
- Transplantation Medicine
- Cell Biology
Background:
- Type 1 diabetes affects over 1 million Americans, with islet transplantation offering a path to insulin independence.
- Current islet transplantation is limited by a severe shortage of suitable donor pancreases.
- In 1999, only 50% of 5882 donated pancreases yielded clinically usable islets.
Purpose of the Study:
- To review potential alternative sources of tissue for islet transplantation.
- To address the critical organ scarcity issue in islet transplantation for type 1 diabetes.
Main Methods:
- Literature review of existing and potential tissue sources for transplantation.
- Focus on human cell sources, including both islet and nonislet cells.
- Consideration of nonhuman sources as supplementary options.
Main Results:
- Identified various human and nonhuman cell types as potential sources for islet transplantation.
- Highlighted the need for diverse tissue procurement strategies to overcome donor organ limitations.
Conclusions:
- Expanding tissue sources beyond traditional donor pancreases is crucial for advancing islet transplantation.
- Further research into alternative human and nonhuman cell sources may significantly increase the availability of transplantable tissue for type 1 diabetes patients.